(Q43734602)

English

Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Helicobacter pylori

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kamberoglou D

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Polymeros D

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sanidas I

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Doulgeroglou V

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Savva S

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Patra E

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Tzias V

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1493-1497

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrate-ranitidine admixture

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01072.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2001.01072.X

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43734602&oldid=2102918333"